| [1] |
Navarrete MD,González MN,Montalvo VM,et al.Patterns of recurrence and survival in breast cancer.Oncol Reports,2008,20:531-535.
|
| [2] |
Brewster A,Hortobagyi G,Broglio K,et al.Residual risk of breast cancer recurrence 5 years after adjuvant therapy.J Natl Cancer Inst,2008,100:1179-1183.
|
| [3] |
Bidard FC,Kirova YM,Vincent Salomon A,et al.Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.Ann Oncol,2009,20:1836-1841.
|
| [4] |
Sanuki FN,Takeda A,Amemiya A,et al.Pattern of tumor recurrence in initially nonmetastatic breast cancer patients:distribution and frequency of metastases at unusual sites.Cancer,2008,113:677-682.
|
| [5] |
Pennery E.The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptorpositive breast cancer.Eur J Oncol Nurs,2008,12:233-243.
|
| [6] |
Fodor J,Major T,Polgár C,et al.Prognosis of patients with local recurrence after mastectomy or conservative surgery for early-stage invasive breast cancer.Breast,2008,17:302-308.
|
| [7] |
Dinh P,Cardoso F,Sotiriou C,et al.New tools for assessing breast cancer recurrence.Cancer Treat Res,2008,141:99-118.
|
| [8] |
Paepke S,Jacobs VR,Ohlinger R,et al.Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer.J Cancer Res Clin Oncol,2007,133:905-916.
|
| [9] |
Sarasqueta C,Martinez Camblor P,Mendiola A,et al.Breast cancer relative survival after the first recurrence and related prognostic factors.Med Clin,2009,133:489-495.
|
| [10] |
Gentilini O,Botteri E.The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence.Am J Surg,2009,198:461-462.
|
| [11] |
Jaffre F,Lavoue V,Mesbah H,et al.Prognosis for isolated skin recurrence after breast cancer treated by mastectomy.Anticancer Res,2009,29:1697-1701.
|
| [12] |
Christiansen P,Al-Suliman N,Bjerre K,et al.Recurrence pattern and prognosis in low-risk breast cancer patients:data from the DBCG 89-A Programme.Acta Oncol,2008,47:691-703.
|
| [13] |
Beadle BM,Woodward WA,Tucker SL,et al.Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.Int J Radiat Oncol Biol Phys,2009,73:734-744.
|
| [14] |
Baltogiannis G,Ziogas D,Fatouros M.Exploring clinical implications of mechanisms for breast cancer local recurrence.Ann Surg Oncol,2009,16:783-784.
|
| [15] |
Hannoun J,Houvenaeghel G,Ellis S,et al.Partial breast irradiation as second conservative treatment for local breast cancer recurrence.Int J Radiat Oncol Biol Phys,2004,60:1385-1392.
|
| [16] |
Clarke M,Collins R,Darby S,et al.Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:an overview of the randomised trials.Lancet,2005,366:2087-2106.
|
| [17] |
Chagpar A,Kuerer HM,Hunt KK,et al.Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage:implications for post-mastectomy radiation therapy.Int J Radiat Oncol Biol Phys,2003,57:128-135.
|
| [18] |
Richards GM,Tome WA,Robins HI,et al.Pulsed reduced dose-rate radiotherapy:a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall,axilla,or supraclavicular region.Breast Cancer Res Treat,2009,114:307-313.
|
| [19] |
Xue LY,Chiu SM,Oleinick NL.Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc4.Oncogene,2001,20:3420-3427.
|
| [20] |
Morris RL,Azizuddin K,Lam M,et a1.Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy.Cancer Res,2003,63:5194-5197.
|
| [21] |
D'hallewin MA,Kochetkov D,Viry Babel Y,et al.Photody-namic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence.Lasers Surg Med,2008,40:543-549.
|
| [22] |
Voogd AC,Cranenbroek S,De Boer R,et al.Long-term prognosis of patients with axillary recurrence after axillary dissection for invasive breast cancer.Eur J Surg Oncol,2005,31:485-489.
|
| [23] |
Pergolizzi S,Adamo V,Russi E,et al.Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases.Int J Radiat Oncol Biol Phys,2006,65:25-32.
|
| [24] |
Pameijer CR,Smith D,MeCahill LE,et al.Full-thickness chest wall resection for recurrent breast carcinoma:an institutional review and meta-analysis.Am Surg,2005,71:711-715.
|
| [25] |
Early Breast Cancer Trialists'Collaborative Group(EBCTCG).Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:an overview of the randomised trials.Lancet,2005,365:1687-1717.
|
| [26] |
Semrau S,Gerber B,Reimer T,et al.Concurrent radiotherapy and taxane chemotherapy in patients with locoregional recurrence of breast cancer:a retrospective analysis.Strahlenther Onkol,2006,182:596-603.
|
| [27] |
Jones SE,Erban J,Overmoyer B,et al.Randomized phaseⅢstudy of docetaxel compared with paclitaxel in metastatic breast.J Clin Oncol,2005,23:5542-5551.
|
| [28] |
Demiray M,Kurt E,Evrensel T,et al.PhaseⅡstudy of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.Cancer Invest,2005,23:386-391.
|
| [29] |
Chan S,Romieu G,Huober J,et al.Phase Ⅲstudy of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer.J Clin Oncol,2009,27:1753-1760.
|
| [30] |
Mansell J,Monypenny I,Skene AI,et al.Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.Breast Cancer Res Treat,2009,117:91-98.
|
| [31] |
Pennery E.The role of endocrine therapies in reducing risk of recurrence in postmenopausal women with hormone receptorpositive breast cancer.Eur J Oncol Nurs,2008,12:233-243.
|
| [32] |
International Breast Cancer Study Group BIG 1-98 Collaborative Group.Design,conduct,and analyses of Breast International Group(BIG)1-98:a randomized,double-blind,phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive,early breast cancer.Clin Trials,2009,6:272-287.
|
| [33] |
Nabholtz JM.Aromatase inhibitors in the management of early breast cancer.Eur J Surg Oncol,2008,34:1199-1207.
|
| [34] |
International Exemestane Study Group.Intergroup exemestane study mature analysis:overall survival data.Anticancer Drugs,2008,19:3-7.
|
| [35] |
Dean CW,Esteva FJ.HER-2 positive breast cancer:herceptin and beyond.Eur J Cancer,2008,44:2806-2812.
|
| [36] |
Traina TA.Bevacizumab in the treatment of metastatic breast cancer.Oncology,2009,23:327-332.
|
| [37] |
Toi M,Iwata H,Fujiwara Y,et al.Lapatinib monotherapy in patients with relapsed,advanced,or metastatic breast cancer:efficacy,safety,and biomarker results from Japanese patients phaseⅡstudies.Br J Cancer,2009,101:1676-1682.
|